Graft SurvivalKidney TransplantationGraft RejectionGraft Occlusion, VascularSurvival RateLiver TransplantationImmunosuppressive AgentsCell SurvivalCadaverTissue DonorsTreatment OutcomeTime FactorsRetrospective StudiesLiving DonorsHeart TransplantationTransplantation, HomologousKeratoplasty, PenetratingBlood Vessel ProsthesisSurvival AnalysisPancreas TransplantationCorneal TransplantationTissue and Organ ProcurementTacrolimusHistocompatibility TestingPostoperative ComplicationsFollow-Up StudiesImmunosuppressionPolytetrafluoroethyleneCyclosporineCold IschemiaDisease-Free SurvivalIslets of Langerhans TransplantationOrgan PreservationTransplantsReoperationSkin TransplantationPrimary Graft DysfunctionDelayed Graft FunctionKaplan-Meier EstimateMycophenolic AcidTransplantation, HeterotopicSurvivalBrain DeathGraft Enhancement, ImmunologicTransplantation ToleranceVascular PatencyPolyethylene TerephthalatesSaphenous VeinLiver FailureTransplantation ImmunologyProportional Hazards ModelsBlood Vessel Prosthesis ImplantationAnastomosis, SurgicalRats, Inbred LewAntilymphocyte SerumRisk FactorsDeathKidney Failure, ChronicIsoantibodiesVeinsOrgan Preservation SolutionsMice, Inbred C57BLHLA AntigensTissue and Organ HarvestingAzathioprineTransplantation, IsogeneicRecurrenceMice, Inbred BALB CKidneyFetal Tissue TransplantationProspective StudiesCoronary Artery BypassTransplantationHistocompatibilityGraft vs Host DiseaseBiopsyCreatinineMultivariate AnalysisDonor SelectionArteriovenous Shunt, SurgicalCorneal NeovascularizationBrain Tissue TransplantationPrognosisRaffinoseIsoantigensComplement C4bRisk AssessmentAge FactorsTransplantation, AutologousTransplantation, HeterologousFemoral ArteryCohort StudiesAntibodies, MonoclonalProsthesis DesignJugular VeinsOrgan TransplantationImmunoconjugatesAcute DiseaseDrug Therapy, CombinationIncidence